Compliance Rate

Compliance Rate 50.0%
Compliant submissions 1
Incompliant submissions 1
Total trials 2

My Organizations' Clinical Trials

Showing 1900 of 3499 entries
View as:

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04692675 Org: User:
Start: 11/18/22 End: 09/01/27 Due: 09/01/28

Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00303836 Org: User:
Start: 11/30/05 End: - Due: -

Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01642251 Org: User:
Start: 09/28/12 End: 07/02/18 Due: 07/02/19

Men at High Genetic Risk for Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03805919 Org: User:
Start: 03/27/19 End: 01/01/39 Due: 01/01/40

A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00001689 Org: User:
Start: 01/31/98 End: 11/30/03 Due: 11/30/04

Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05996523 Org: User:
Start: 11/07/23 End: 11/01/28 Due: 11/01/29

Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00095667 Org: User:
Start: 11/30/04 End: - Due: -

Internet-Based and Self-Reports in Assessing Diet and Physical Activity Within AARP

Phase: N/A Priority: Normal
NCT ID: NCT03268577 Org: User:
Start: 01/01/12 End: 12/31/13 Due: 12/31/14

Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02595879 Org: User:
Start: 09/18/19 End: 04/29/26 Due: 04/29/27

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01771107 Org: User:
Start: 03/07/13 End: 02/28/25 Due: 02/28/26

Family Study of Melanoma in Italy

Phase: N/A Priority: Normal
NCT ID: NCT00339222 Org: User:
Start: 11/05/01 End: 06/30/20 Due: 06/30/21

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01122901 Org: User:
Start: 12/31/10 End: 08/31/15 Due: 08/31/16

Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma

Phase: N/A Priority: Normal
NCT ID: NCT01236560 Org: User:
Start: 01/26/11 End: 12/31/23 Due: 12/31/24

Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00468910 Org: User:
Start: 03/31/07 End: 08/31/11 Due: 08/31/12

Early Detection of Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00341523 Org: User:
Start: 11/01/16 End: 04/29/24 Due: 04/29/25

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05896839 Org: User:
Start: 07/24/24 End: 01/31/27 Due: 01/31/28

Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial

Phase: N/A Priority: Normal
NCT ID: NCT05237947 Org: User:
Start: 03/01/22 End: 05/31/26 Due: 05/31/27

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05950464 Org: User:
Start: 12/18/23 End: 04/30/26 Due: 04/30/27

Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall

Phase: N/A Priority: Normal
NCT ID: NCT00089544 Org: User:
Start: 06/17/04 End: 11/05/13 Due: 11/05/14

Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00134069 Org: User:
Start: 06/30/05 End: 12/31/11 Due: 12/31/12

Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00971789 Org: User:
Start: 07/31/08 End: 10/31/12 Due: 10/31/13

Feasibility Study of a Web-Based Automated Self-Administered 24-hour Dietary Recall (ASA 24) and a Physical Activity 24-hour Recall

Phase: N/A Priority: Normal
NCT ID: NCT01164254 Org: User:
Start: 05/28/08 End: 11/30/16 Due: 11/30/17

BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00287495 Org: User:
Start: 02/02/06 End: 10/18/17 Due: 10/18/18

Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02178241 Org: User:
Start: 12/11/14 End: 07/11/19 Due: 07/11/20

A Study of Patients Receiving High-Dose Rate Brachytherapy

Phase: N/A Priority: Normal
NCT ID: NCT00924027 Org: User:
Start: 04/14/09 End: 07/05/25 Due: 07/05/26